Feng, Zheng
Shao, Di
Cai, Yuhang
Bi, Rui
Ju, Xingzhu
Chen, Dongju
Song, Chengcheng
Chen, Xiaojun
Li, Jin
An, Na
Li, Yunjin
Zhou, Qing
Xiu, Zhihui
Zhu, Shida
Wu, Xiaohua
Wen, Hao
Article History
Received: 13 December 2022
Accepted: 27 February 2023
First Online: 15 March 2023
Declarations
:
: The trial protocol was approved by the Institutional Reviewer Board of Fudan University Shanghai Cancer Center and BGI (NO. 1703170–15 and NO. BGI-IRB 19151-T2), and the trial was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. Informed consent was obtained from all patients.
: Not applicable.
: Di Shao, Yuhang Cai, Dongju Chen, Chengcheng Song, Na An, Yunjin Li, Qing Zhou, Zhihui Xiu and Shida Zhu are employees of BGI Genomics. The remaining authors declare no conflict of interest.